Heba Alshaker

IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors

Heba Alshaker, Khalid Z. Matalka · Cancer Cell International · 2011 · 110 citations · Full text

Medicine, Immunology, Oncology +17

Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation

Filipa G. Pinho, Adam E. Frampton, João Nunes et al. · Cancer Research · 2013 · 90 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer

Qi Wang, Heba Alshaker, Torsten Böhler et al. · Scientific Reports · 2017 · 80 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway

Heba Alshaker, Jonathan Krell, Adam E. Frampton et al. · Breast Cancer Research · 2014 · 73 citations · Full text

Medicine, Endocrinology, Oncology +17

Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time

Heba Alshaker, Nidal A. Qinna, Fadi Qadan et al. · BMC Complementary and Alternative Medicine · 2011 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17